spacer
home > epc > autumn 2003 > recruiting hiv infected patients for anti-retroviral clinical trials in cee and the russian federation
PUBLICATIONS
European Pharmaceutical Contractor

Recruiting HIV Infected Patients for Anti-Retroviral Clinical Trials in CEE and the Russian Federation

Over the past decade the number of international clinical trials performed in Central and Eastern Europe (CEE) has continuously increased. Amongst these countries, Poland has become a regular partner in the conduct of clinical trials although this is not yet the case for most other CEE countries. Since the start of the first trial in the Russian Federation only about 120 trials have been conducted there (1). However, given the positive aspects of performing clinical trials in CEE countries and the Russian Federation, one can expect the number of trials to increase over time. To explain, site staff tend to be very motivated and eager to participate in clinical trials, while the quality of work and ICH GCP compliance is largely impeccable. Even more important when conducting clinical trials, recruitment in CEE countries and the Russian Federation appears to be higher than in most Western European countries. This again is not only because of the motivated staff but also because of the availability of the potential trial population.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Stefan Comhaire, Project Manager at Medisearch International

Having begun his career in basic scientific research, Stefan Comhaire joined Medisearch International over five years ago. Starting in clinical research as a CRA, he is now a Project Manager in charge of setting up the collaboration with the CEE and the Russian Federation five years ago, during which he established long-lasting collaboration with Russian and Polish investigators. As a specialist in infectious diseases, he has led several clinical trials in HIV, most of them also recruiting in Eastern Europe and/or Russia.

spacer
Stefan Comhaire
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

MedPharm’s CSO and University of Reading Professor co-author new book on dermal formulation development

MedPharm’s Chief Scientific Officer and Co-Founder, Professor Marc Brown and University of Reading’s Professor Adrian Williams have co-authored the new book: ‘The Art and Science of Dermal Formulation Development”. It is the latest addition to ‘Drugs and the Pharmaceutical Sciences’, a series of textbooks and monographs published by CRC Press.
More info >>

White Papers
 
Industry Events

The Universe of Pre-filled Syringes and Injection Devices

22-23 October 2019, The Swedish Exhibition & Congress Centre Gothia Towers Hotel

PDA’s Universe of Pre-filled Syringes and Injection Devices has become the must-attend meeting for everyone working in the field, and is now the world’s largest conference on this subject
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement